A decision-ready blueprint
An SEO and AI search visibility programme designed around the commercial realities of life science vc & investment firms.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Investment teams and portfolio leaders need high-science assets to be discoverable and accurately understood when potential partners, acquirers, and investors conduct initial market research. SEO and AI search visibility create the evidence and content architecture that supports a clearer, more credible public representation of those assets.
Lonrú Consulting designs visibility programmes around the portfolio questions that matter to a fund and its companies. The work brings together approved scientific, clinical, commercial, and market material, then creates a governed route for presenting it, reviewing it, and measuring where external discovery needs strengthening.
We define the approved portfolio, company, scientific, clinical, commercial, and published sources relevant to the selected discovery or value-creation question.
Configured systems analyse approved evidence, identify information gaps and priority questions, and prepare structured content or comparative material for review.
Lonrú provides principal-led strategy and review governance. Fund, portfolio-company, scientific, legal, and commercial owners review material within their own decision rights.
The programme is delivered through a practical evidence, content, and measurement view that helps teams assess visibility, market questions, and the next priority for an asset or portfolio.
Structure approved scientific and commercial evidence so an asset's value proposition can be found and assessed with the relevant source context intact.
Relate publications, clinical information, corporate material, and market context without presenting confidential diligence conclusions as public fact.
Provide a practical view of where priority assets have a strong public evidence base, where information gaps exist, and where content investment should be focused.
Define the role, source boundaries, and review process for each company so public representation remains accurate without blurring ownership or confidentiality.
The programme strengthens the approved public evidence available to discovery systems and measures how priority assets are being found and understood. Investment recommendations, confidential diligence material, valuations, and transaction decisions remain within the fund's established process.
We establish which information can be used for public representation, who reviews it, and how the programme relates to the fund's and portfolio company's own governance before work begins.
Relevant experience
Interactive SaaS
Engineered and deployed an interactive SaaS trial-tracking platform, VantagePoint Insights™, with an advanced-therapy Voice of Customer database that maps pipeline maturity, modality, and vector dominance for industry stakeholders.
Delivered growth
Built and executed an integrated life-science SEO and AI search visibility growth programme for a specialist provider. The work connected market positioning, approved technical evidence, content architecture, publication, search intelligence, and ongoing measurement, materially increasing first-page search presence and establishing measurable visibility across generative discovery journeys.
Architecture in context
Diagram summary: Approved portfolio evidence is contextualised, analysed, and tested through ActiveArchitecture™ before it supports clearer asset discovery and value-creation priorities.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefing